Literature DB >> 3349230

Gastric mucosal damage induced by local intra-arterial administration of Paf in the rat.

J V Esplugues1, B J Whittle.   

Abstract

1. A technique for the close-arterial administration of substances to the rat stomach in vivo has been developed. 2. Intra-arterial infusion of platelet-activating factor (Paf, 10-50 ng kg-1 min-1 for 10 min) induced macroscopically assessed damage in the corpus mucosa, characterized as vasocongestion and necrosis. 3. The threshold intra-arterial doses of Paf that induced histologically assessed damage in the antrum and corpus of the stomach (10 and 5 ng kg-1 min-1, respectively) produced minimal systemic hypotension (less than 20 mmHg) suggesting a dissociation between these events. 4. Pretreatment with the Paf-antagonist, L-652,731 (2.5 mg kg-1 i.v.) prevented the gastric damage induced by local infusion of Paf. 5. Intravenous infusion of Paf (25 ng kg-1 min-1) did not significantly damage the gastric mucosa, in contrast to the same dose infused locally, yet Paf administered by either route produced a comparable degree of hypotension. Such findings suggest minimal metabolism of Paf during its passage through the gastric circulation. 6. Local intra-arterial infusion of Paf in doses as low as 0.25 ng kg-1 min-1, which had no systemic hypotensive actions, significantly induced gastric damage in the presence of intragastric 20% ethanol. 7. These observations support a local role for Paf in the pathogenesis of gastric irritation and ulceration, such as that observed during endotoxin shock or bacterial infection. The present technique is thus useful for the study of locally administered substances on gastric function and integrity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3349230      PMCID: PMC1853784          DOI: 10.1111/j.1476-5381.1988.tb11425.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  17 in total

1.  Effects of inhibitors of arachidonic acid metabolism on Paf-induced gastric mucosal necrosis and haemoconcentration.

Authors:  J L Wallace; B J Whittle
Journal:  Br J Pharmacol       Date:  1986-10       Impact factor: 8.739

2.  Gastric vascular and mucosal damaging actions of platelet activating factor in the canine stomach.

Authors:  B J Whittle; G L Kauffman; J L Wallace
Journal:  Adv Prostaglandin Thromboxane Leukot Res       Date:  1987

3.  Prevention of endotoxin-induced gastrointestinal damage by CV-3988, an antagonist of platelet-activating factor.

Authors:  J L Wallace; B J Whittle
Journal:  Eur J Pharmacol       Date:  1986-05-13       Impact factor: 4.432

4.  A revisit to the experimental production of gastric ulcers by vascular ligation.

Authors:  P H Guth
Journal:  Am J Dig Dis       Date:  1972-08

5.  Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit.

Authors:  L M McManus; D J Hanahan; C A Demopoulos; R N Pinckard
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

6.  Inhibition of the platelet activating factor (PAF)-induced in vivo responses in rats by trans-2,5-(3,4,5-trimethoxyphenyl) tetrahydrofuran (L-652,731), a PAF receptor antagonist.

Authors:  M S Wu; T Biftu; T W Doebber
Journal:  J Pharmacol Exp Ther       Date:  1986-12       Impact factor: 4.030

7.  Microvascular actions of platelet-activating factor on rat gastric mucosa and submucosa.

Authors:  B J Whittle; T Morishita; Y Ohya; F W Leung; P H Guth
Journal:  Am J Physiol       Date:  1986-12

8.  Potent ulcerogenic actions of platelet-activating factor on the stomach.

Authors:  A C Rosam; J L Wallace; B J Whittle
Journal:  Nature       Date:  1986 Jan 2-8       Impact factor: 49.962

9.  trans-2,5-Bis-(3,4,5-trimethoxyphenyl)tetrahydrofuran. An orally active specific and competitive receptor antagonist of platelet activating factor.

Authors:  S B Hwang; M H Lam; T Biftu; T R Beattie; T Y Shen
Journal:  J Biol Chem       Date:  1985-12-15       Impact factor: 5.157

10.  Picomole doses of platelet-activating factor predispose the gastric mucosa to damage by topical irritants.

Authors:  J L Wallace; B J Whittle
Journal:  Prostaglandins       Date:  1986-05
View more
  13 in total

1.  Therapeutic effect of DA-9601 on chronic reflux gastritis induced by sodium taurocholate in rats.

Authors:  Tae Young Oh; Chang Yell Shin; Yong Sung Sohn; Dong Hwan Kim; Byoung Ok Ahn; Eun Bang Lee; Cho Hyun Park
Journal:  World J Gastroenterol       Date:  2005-12-21       Impact factor: 5.742

2.  Proceedings of the British Pharmacological Society. London, 19th-21st December. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

3.  Possible pathogenic mechanisms of Campylobacter pylori.

Authors:  D Fumarola; G Miragliotta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-08       Impact factor: 3.267

4.  Induction of rat gastric damage by the endothelium-derived peptide, endothelin.

Authors:  B J Whittle; J V Esplugues
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

Review 5.  Thirteenth Gaddum Memorial Lecture. Neuronal and endothelium-derived mediators in the modulation of the gastric microcirculation: integrity in the balance.

Authors:  B J Whittle
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

6.  Gastric damage following local intra-arterial administration of reactive oxygen metabolites in the rat.

Authors:  J V Esplugues; B J Whittle
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

7.  Verotoxin induces hemorrhagic lesions in rat small intestine. Temporal alteration of vasoactive substances.

Authors:  H Tashiro; S Miura; I Kurose; D Fukumura; H Suzuki; M Suematsu; M Yoshioka; M Tsuchiya; A Kai; Y Kudoh
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

8.  Local opioid-sensitive afferent sensory neurones in the modulation of gastric damage induced by Paf.

Authors:  J V Esplugues; B J Whittle; S Moncada
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

9.  Dexamethasone-induced gastric mucosal damage in the rat: possible role of platelet-activating factor.

Authors:  J G Filep; F Hermán; E Földes-Filep; F Schneider; P Braquet
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

10.  Significance and regulation of gastric secretion of platelet-activating factor (PAF-acether) in man.

Authors:  I Sobhani; Y Denizot; C Vissuzaine; J Vatier; J Benveniste; M J Lewin; M Mignon
Journal:  Dig Dis Sci       Date:  1992-10       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.